REVB vs. JAGX, GRI, ELAB, ADTX, VCNX, PBM, QLGN, VRAX, ADIL, and OGEN
Should you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include Jaguar Animal Health (JAGX), GRI Bio (GRI), PMGC (ELAB), Aditxt (ADTX), Vaccinex (VCNX), Psyence Biomedical (PBM), Qualigen Therapeutics (QLGN), Virax Biolabs Group (VRAX), Adial Pharmaceuticals (ADIL), and Oragenics (OGEN). These companies are all part of the "pharmaceutical products" industry.
Revelation Biosciences vs. Its Competitors
Jaguar Animal Health (NASDAQ:JAGX) and Revelation Biosciences (NASDAQ:REVB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.
In the previous week, Revelation Biosciences had 3 more articles in the media than Jaguar Animal Health. MarketBeat recorded 4 mentions for Revelation Biosciences and 1 mentions for Jaguar Animal Health. Revelation Biosciences' average media sentiment score of 0.19 beat Jaguar Animal Health's score of -0.34 indicating that Revelation Biosciences is being referred to more favorably in the news media.
Revelation Biosciences has lower revenue, but higher earnings than Jaguar Animal Health.
Jaguar Animal Health currently has a consensus price target of $60.00, suggesting a potential upside of 2,239.18%. Given Jaguar Animal Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Jaguar Animal Health is more favorable than Revelation Biosciences.
Jaguar Animal Health has a beta of 0.56, indicating that its stock price is 44% less volatile than the S&P 500. Comparatively, Revelation Biosciences has a beta of -0.08, indicating that its stock price is 108% less volatile than the S&P 500.
Revelation Biosciences has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -343.92%. Revelation Biosciences' return on equity of -299.46% beat Jaguar Animal Health's return on equity.
12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 12.8% of Revelation Biosciences shares are owned by institutional investors. 0.4% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 2.3% of Revelation Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Revelation Biosciences beats Jaguar Animal Health on 7 of the 13 factors compared between the two stocks.
Get Revelation Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding REVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Revelation Biosciences Competitors List
Related Companies and Tools
This page (NASDAQ:REVB) was last updated on 7/6/2025 by MarketBeat.com Staff
Free REVB Stock Alerts